Roche’s Elecsys PTau217 Blood Test Receives FDA Breakthrough Designation For Alzheimer’s Detection
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Roche (RHHBY) said that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1485050088-ee61e8a68f4c4bbd826570b8f2594955.jpg "<div>Want to Retire in the U.K. as an American? Here's How</div>")
